Palmerola Ricardo, Patel Vinay, Hartman Christopher, Sung Chris, Hoenig David, Smith Arthur D, Okeke Zeph
Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA.
Interventional Radiology, Northwell Health, New Hyde Park, NY, USA.
Asian J Urol. 2017 Jan;4(1):27-30. doi: 10.1016/j.ajur.2016.08.012. Epub 2016 Sep 6.
Selective angioembolization (SAE) effectively diagnoses and treats iatrogenic vascular complications following percutaneous nephrolithotomy (PCNL).
We retrospectively reviewed 1329 consecutive PCNLs and identified patients who underwent SAE following PCNL with at least 12-month follow-up. Estimated glomerular filtration rate (eGFR) was calculated for all patients preoperatively, postoperatively and at last follow-up. A 1:2 matched cohort analysis was performed.
Twenty-three patients underwent SAE and matched to 46 controls. There was no statistically significant difference in preoperative, postoperative, and follow-up eGFR when comparing patients who underwent SAE and those with an uneventful course.
Long-term eGFR is comparable in patients who undergo uncomplicated PCNL and those requiring SAE.
选择性血管栓塞术(SAE)能有效诊断和治疗经皮肾镜取石术(PCNL)后的医源性血管并发症。
我们回顾性分析了连续1329例PCNL病例,并确定了PCNL术后接受SAE且至少随访12个月的患者。计算所有患者术前、术后及末次随访时的估计肾小球滤过率(eGFR)。进行1:2匹配队列分析。
23例患者接受了SAE,并与46例对照匹配。比较接受SAE的患者和病程平稳的患者,术前、术后及随访时的eGFR无统计学显著差异。
未发生并发症的PCNL患者和需要SAE的患者的长期eGFR相当。